Ligand Pharmaceuticals LGND Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.35M-130% | $44.78M-61.8% | $117.27M+2,319% | $4.85M+111% | -$42.45M-36.6% | ||
| $8.22M0.0% | $8.21M-0.7% | $8.27M-3.0% | $8.52M-2.8% | $8.77M+1.7% | ||
| $10.6M-25.7% | $14.27M-3.2% | $14.75M+47.5% | $10M+27.6% | $7.84M+4.1% | ||
| $48.69M+6.0% | $45.92M+251% | $13.09M-17.1% | $15.8M+162% | -$25.45M-189% | ||
| $228K+2,433% | $9K-40.0% | $15K-93.0% | $214K0.0% | $214K-69.9% | ||
| -$94.35M-421% | -$18.1M+94.9% | -$353.45M-3,213% | -$10.67M-318% | $4.89M+113% | ||
| -$14.13M-270% | $8.33M-98.0% | $409.65M+2,632% | $15M+416% | -$4.75M-123% | ||
| -$59.83M-268% | $35.55M-50.4% | $71.71M+264% | $19.68M+181% | -$24.32M-380% | ||
| $48.46M+5.6% | $45.91M+251% | $13.08M-16.1% | $15.59M+161% | -$25.66M-192% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Ligand Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ligand Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.